Literature DB >> 12354806

Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections.

J Xu1, B C Millar, J E Moore, R McClurg, M J Walker, J Evans, S Hedderwick, R McMullan.   

Abstract

A study was carried out to compare the API20C technology with polymerase chain reaction amplification and direct sequencing of the short internal transcribed spacer region 2 (ITS2) for the identification of 58 isolates of invasive candida species obtained from patients with bloodstream infections over the seven year period 1994 to 2000. Overall, there was only one disagreement between the phenotypic and genotypic identification, where the API scheme identified the isolate as C albicans but the molecular method identified it as C dubliniensis. This study demonstrated that the API20C method is useful in the identification of Candida spp isolated from blood culture and that molecular methods do not enhance identifications made using the API20C scheme. However, for correct reporting of C dubliniensis, an emerging bloodborne pathogen, it is recommended that all isolates identified as C albicans by the API20C scheme are further examined phenotypically and/or genotypically.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354806      PMCID: PMC1769787          DOI: 10.1136/jcp.55.10.774

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility.

Authors:  J L Rowen; J M Tate; N Nordoff; L Passarell; M R McGinnis
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Long-term preservation of strains of Burkholderia cepacia, Pseudomonas spp. and Stenotrophomonas maltophilia isolated from patients with cystic fibrosis.

Authors:  J E Moore; A B Shaw; T Stanley; M J Crowe; J S Elborn
Journal:  Lett Appl Microbiol       Date:  2001-07       Impact factor: 2.858

3.  A simple and sensitive method to extract bacterial, yeast and fungal DNA from blood culture material.

Authors:  B C Millar; X Jiru; J E Moore; J A Earle
Journal:  J Microbiol Methods       Date:  2000-10       Impact factor: 2.363

4.  Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes.

Authors:  Y C Chen; J D Eisner; M M Kattar; S L Rassoulian-Barrett; K LaFe; S L Yarfitz; A P Limaye; B T Cookson
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Molecular diagnosis of infective endocarditis--a new Duke's criterion.

Authors:  B Millar; J Moore; P Mallon; J Xu; M Crowe; R Mcclurg; D Raoult; J Earle; R Hone; P Murphy
Journal:  Scand J Infect Dis       Date:  2001

6.  Direct amplification of rRNA genes in diagnosis of bacterial infections.

Authors:  K Rantakokko-Jalava; S Nikkari; J Jalava; E Eerola; M Skurnik; O Meurman; O Ruuskanen; A Alanen; E Kotilainen; P Toivanen; P Kotilainen
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections.

Authors:  C Ferrer; F Colom; S Frasés; E Mulet; J L Abad; J L Alió
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 8.  Emerging pathogens.

Authors:  J Pontón; R Rüchel; K V Clemons; D C Coleman; R Grillot; J Guarro; D Aldebert; P Ambroise-Thomas; J Cano; A J Carrillo-Muñoz; J Gené; C Pinel; D A Stevens; D J Sullivan
Journal:  Med Mycol       Date:  2000       Impact factor: 4.076

9.  Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron.

Authors:  M Tamura; K Watanabe; Y Mikami; K Yazawa; K Nishimura
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

10.  Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species.

Authors:  T J Lott; R J Kuykendall; E Reiss
Journal:  Yeast       Date:  1993-11       Impact factor: 3.239

View more
  6 in total

1.  Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system.

Authors:  Peter C Iwen; Alison G Freifeld; Tricia A Bruening; Steven H Hinrichs
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

2.  Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum.

Authors:  Ryan K Shields; M Hong Nguyen; Chen Du; Ellen Press; Shaoji Cheng; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

3.  Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.

Authors:  Laura Judith Marcos-Zambrano; Pilar Escribano; Carlos Sánchez; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

4.  High-throughput identification and quantification of Candida species using high resolution derivative melt analysis of panfungal amplicons.

Authors:  Tasneem Mandviwala; Rupali Shinde; Apoorv Kalra; Jack D Sobel; Robert A Akins
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

5.  Patients with long-term oral carriage harbor high-persister mutants of Candida albicans.

Authors:  Michael D Lafleur; Qingguo Qi; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

6.  Misidentification of Candida guilliermondii as C. famata among strains isolated from blood cultures by the VITEK 2 system.

Authors:  Si Hyun Kim; Jeong Hwan Shin; Jeong Ha Mok; Shine Young Kim; Sae Am Song; Hye Ran Kim; Joong-Ki Kook; Young-Hyo Chang; Il Kwon Bae; Kwangha Lee
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.